John Quisel, J.D., Ph.D., is a distinguished leader in the biotechnology industry, currently serving as the President and Chief Executive Officer at DISC MEDICINE INC. With a unique blend of legal and scientific expertise, John holds a Juris Doctor degree and a Doctorate in Philosophy, which have equipped him with a comprehensive understanding of both the scientific and regulatory landscapes of the pharmaceutical sector. Before joining DISC MEDICINE INC, John held several high-profile positions, including Chief Operating Officer at bluebird bio, where he played a pivotal role in advancing the company's gene therapy programs. At DISC MEDICINE INC, John Quisel has been instrumental in steering the company towards its mission of developing innovative treatments for serious hematologic diseases. Under his leadership, the company has made significant strides in advancing its clinical pipeline, which includes several promising drug candidates aimed at addressing unmet medical needs. John's strategic vision and commitment to scientific excellence have been key factors in attracting top talent and securing partnerships that have bolstered the company's growth and development. John's achievements extend beyond his role at DISC MEDICINE INC. He is recognized in the industry for his contributions to the field of biotechnology, having authored numerous publications and patents. His ability to navigate complex regulatory environments and his dedication to patient-centric innovation have earned him a reputation as a respected leader and advocate for the advancement of medical science. John continues to inspire and lead DISC MEDICINE INC towards new heights, driven by a passion for transforming the lives of patients through groundbreaking therapies.